230 related articles for article (PubMed ID: 26190483)
1. Insulin resistance and hepatocarcinogenesis.
Sasaki Y
Clin J Gastroenterol; 2010 Dec; 3(6):271-8. PubMed ID: 26190483
[TBL] [Abstract][Full Text] [Related]
2. Development and prognosis of hepatocellular carcinoma in patients with diabetes.
Nakatsuka T; Tateishi R
Clin Mol Hepatol; 2023 Jan; 29(1):51-64. PubMed ID: 35903020
[TBL] [Abstract][Full Text] [Related]
3. Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
Arfianti A; Pok S; Barn V; Haigh WG; Yeh MM; Ioannou GN; Teoh NC; Farrell GC
J Hepatol; 2020 Jul; 73(1):140-148. PubMed ID: 32302728
[TBL] [Abstract][Full Text] [Related]
4. [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
Kwon OS; Kim JH; Kim JH
Korean J Gastroenterol; 2017 Jun; 69(6):348-352. PubMed ID: 28637103
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
6. Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers.
Fu XX; Su CY; Lee Y; Hintz R; Biempica L; Snyder R; Rogler CE
J Virol; 1988 Sep; 62(9):3422-30. PubMed ID: 2457114
[TBL] [Abstract][Full Text] [Related]
7. Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.
Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A
Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
9. Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
Miyazaki T; Shirakami Y; Kubota M; Ideta T; Kochi T; Sakai H; Tanaka T; Moriwaki H; Shimizu M
Oncotarget; 2016 Mar; 7(9):10448-58. PubMed ID: 26871288
[TBL] [Abstract][Full Text] [Related]
10. Obesity-associated mechanisms of hepatocarcinogenesis.
Karagozian R; Derdák Z; Baffy G
Metabolism; 2014 May; 63(5):607-17. PubMed ID: 24629562
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice.
Hines IN; Hartwell HJ; Feng Y; Theve EJ; Hall GA; Hashway S; Connolly J; Fecteau M; Fox JG; Rogers AB
Am J Pathol; 2011 Dec; 179(6):2855-65. PubMed ID: 21967816
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association.
Petta S; Craxì A
Curr Pharm Des; 2010; 16(6):741-52. PubMed ID: 20388084
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P; Romeo S; Valenti L
World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
[TBL] [Abstract][Full Text] [Related]
15. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry.
Yang DY; Rogler CE
Carcinogenesis; 1991 Oct; 12(10):1893-901. PubMed ID: 1657428
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
[TBL] [Abstract][Full Text] [Related]
17. [Role of environmental factors in the etiology of hepatocellular carcinoma].
Tornai I
Orv Hetil; 2010 Jul; 151(28):1132-6. PubMed ID: 20570793
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
Baffy G; Brunt EM; Caldwell SH
J Hepatol; 2012 Jun; 56(6):1384-91. PubMed ID: 22326465
[TBL] [Abstract][Full Text] [Related]
19. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment.
Agosti P; Sabbà C; Mazzocca A
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):607-617. PubMed ID: 29197664
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and chronic liver disease.
Kawaguchi T; Taniguchi E; Itou M; Sakata M; Sumie S; Sata M
World J Hepatol; 2011 May; 3(5):99-107. PubMed ID: 21731901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
